Inpatient Use and Outcomes at Children's Hospitals During the Early COVID-19 Pandemic

Jessica L Markham1,2, Troy Richardson3,4, Adrienne DePorre3,2

  • 1Department of Pediatrics, Children's Mercy Kansas City and School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri; jlmarkham@cmh.edu.

Pediatrics
|March 24, 2021
PubMed

Insights

The COVID-19 pandemic caused a 35% drop in pediatric hospitalizations, especially for respiratory illnesses like asthma and pneumonia. Hospital outcomes such as length of stay and mortality remained stable during this period.

Area of Science:

  • Pediatric Health
  • Epidemiology
  • Health Services Research

Background:

  • The COVID-19 pandemic significantly altered healthcare utilization patterns globally.
  • Children's emergency department visits decreased, prompting an investigation into inpatient trends.

Purpose of the Study:

  • To analyze the impact of the COVID-19 pandemic on inpatient utilization within children's hospitals.
  • To compare inpatient use and clinical outcomes before and during the pandemic.

Main Methods:

  • Retrospective study utilizing the Pediatric Health Information System (PHIS).
  • Comparison of inpatient data from March 15 to August 29, 2020 (COVID-19 period) with the same period in the preceding three years (pre-COVID-19).
  • Analysis using adjusted generalized linear mixed models for trends and outcomes across 15 All Patient Refined Diagnosis Related Groups (APR-DRGs).

Main Results:

  • A total of 424,856 hospitalizations pre-COVID-19 and 91,532 during the COVID-19 period were analyzed.
  • Overall hospitalizations declined by 35.1%, with significant reductions for asthma (81.3%), bronchiolitis (80.1%), and pneumonia (71.4%).
  • Readmission rates decreased during the pandemic, while length of stay, cost, ICU use, and mortality remained largely consistent.

Conclusions:

  • US children's hospitals experienced substantial decreases in inpatient admissions during the COVID-19 pandemic.
  • Clinical outcomes at the hospital level remained largely unchanged, despite variations in utilization by condition.
  • Respiratory conditions, including asthma, bronchiolitis, and pneumonia, saw the most significant declines in inpatient admissions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
76
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
87
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
114
Hospitals-II00:59

Hospitals-II

Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in...
899
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
85
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K